Cover Image

Risk of Non-melanoma Skin Cancer in Patients with Atopic Dermatitis Treated with Oral Immunosuppressive Drugs

There is uncertainty about the risk of developing non-melanoma skin cancer (NMSC), including basal cell carcinoma and squamous cell carcinoma (SCC), in patients with atopic dermatitis (AD) treated with oral immunosuppressive drugs. A total of 557 patients with AD treated with these drugs in the Univ...

Full description

Saved in:

Bibliographic Details
Main Authors:	Floor M. Garritsen (Author), Jorien van der Schaft (Author), Juul M. Reek (Author), Klaziena Politiek (Author), Harmieke van den Os-Medendorp (Author), Marijke van Dijk (Author), Dirk J. Hijnen (Author), Marlies de Graaf (Author), Carla A. Bruijnzeel-Koomen (Author), Elke M. de Jong (Author), Marie-Louise A. Schuttelaar (Author), Marjolein S. Bruin-Weller (Author)
Format:	Book
Published:	Medical Journals Sweden, 2017-03-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Allopurinol Co-prescription Improves the Outcome of Azathioprine Treatment in Chronic Eczema
by: Floor M. Garritsen, et al.
Published: (2017)

Economic Burden of Adult Patients with Moderate to Severe Atopic Dermatitis Indicated for Systemic Treatment
by: Lieneke F.M. Ariëns, et al.
Published: (2019)

Daily Practice Experience of Baricitinib Treatment for Patients with Difficult-to-Treat Atopic Dermatitis: Results from the BioDay Registry
by: Celeste M. Boesjes, et al.
Published: (2022)

Real-world Experience of Abrocitinib Treatment in Patients with Atopic Dermatitis and Hand Eczema: Up to 28-week Results from the BioDay Registry
by: Esmé Kamphuis, et al.
Published: (2024)

Health Literacy and Associated Factors in Subjects with Hand Eczema: A Dutch Population-based Study
by: Laura Loman, et al.
Published: (2024)

Rapid and Sustained Effect of Dupilumab on Work Productivity in Patients with Difficult-to-treat Atopic Dermatitis: Results from the Dutch BioDay Registry
by: Lieneke F.M. Ariëns, et al.
Published: (2021)

Successful Treatment with Dupilumab in a Patient with Severe, Difficult to Treat Atopic Dermatitis: Beware of Symptomatic Adrenal Insufficiency due to Abrupt Discontinuation of Potent Topical Corticosteroids
by: Lieneke F.M. Ariëns, et al.
Published: (2018)

Real-world Data Reveal Long Drug Survival for Guselkumab in Patients with Plaque Psoriasis
by: Marloes E. van Muijen, et al.
Published: (2022)

Underestimated Factors Regarding the Use of Technology in Daily Practice of Long-Term Care: Qualitative Study Among Health Care Professionals
by: Sjors W M Groeneveld, et al.
Published: (2023)

Biologicals for pediatric patients with atopic dermatitis: practical challenges and knowledge gaps
by: Lisa P. van der Rijst, et al.
Published: (2023)

Effectiveness of Upadacitinib in Patients with Atopic Dermatitis including those with Inadequate Response to Dupilumab and/or Baricitinib: Results from the BioDay Registry
by: Celeste M. Boesjes, et al.
Published: (2023)

Identification of Risk Factors for Dupilumab-associated Ocular Surface Disease in Patients with Atopic Dermatitis
by: Roselie E. Achten, et al.
Published: (2022)

Economic and Humanistic Burden in Paediatric Patients with Atopic Dermatitis
by: Roselie Achten, et al.
Published: (2023)

Dupilumab Versus Cyclosporine for the Treatment of Moderate-to-Severe Atopic Dermatitis in Adults: Indirect Comparison Using the Eczema Area and Severity Index
by: Lieneke F.M. Ariëns, et al.
Published: (2019)

Short term effectiveness and experiences of a peer guided web-based self-management intervention for young adults with juvenile idiopathic arthritis
by: Judy Ammerlaan, et al.
Published: (2017)

Herpes Simplex Virus Infection Mimicking Bullous Disease in an Immunocompromised Patient
by: Anne L.Y. Lecluse, et al.
Published: (2010)

Effectiveness and Cost-Effectiveness of eHealth Interventions in Somatic Diseases: A Systematic Review of Systematic Reviews and Meta-Analyses
by: Elbert, Niels J, et al.
Published: (2014)

Global Risk of Bacterial Skin Infections and Herpesviridae Infections with Ustekinumab, Secukinumab, and Tumour Necrosis Factor-alpha Inhibitors: Spontaneous Reports of Adverse Drug Reactions from the World Health Organization Pharmacovigilance Center
by: Linda Davidson, et al.
Published: (2022)

Prevalence and predictors of inappropriate prescribing in outpatients with severe mental illness
by: Lisanne Koomen, et al.
Published: (2023)

The role of the nurse in the care and management of patients with atopic dermatitis
by: Harmieke van Os-Medendorp, et al.
Published: (2020)

Evaluation of a One-step Dose Reduction Strategy of Adalimumab, Etanercept and Ustekinumab in Patients with Psoriasis in Daily Practice
by: Selma Atalay, et al.
Published: (2021)

Efficacy and Safety of Tildrakizumab in Older Patients: Pooled Analyses of Two Randomized Phase III Clinical Trials (reSURFACE 1 and reSURFACE 2) Through 244 Weeks
by: Elke L. M. ter Haar, et al.
Published: (2023)

Beliefs About Medicines in Patients with Psoriasis Treated with Methotrexate or Biologics: A Cross-sectional Survey Study
by: Marisol E. Otero, et al.
Published: (2019)

Discovery of Psoriatic Arthritis in Psoriasis Patients for Early Rheumatological Referral (DAPPER) Study: A Prospective Observational Cohort
by: Tamara W. van Hal, et al.
Published: (2022)

Initial Results of Secukinumab Drug Survival in Patients with Psoriasis: A Multicentre Daily Practice Cohort Study
by: Juul M.P.A. van den Reek, et al.
Published: (2018)

Prevalence, risk and severity of SARS-CoV-2 infections in psoriasis patients receiving conventional systemic, biologic or topical treatment during the COVID-19 pandemic: a cross-sectional cohort study (PsoCOVID)
by: Kevin V. Kwee, et al.
Published: (2023)

Development of a New Referral Tool to Identify Psoriasis Patients with Concomitant Psoriatic Arthritis: Results of the Prospective DAPPER Cohort
by: Tamara W. van Hal, et al.
Published: (2023)

Is Telemedicine Suitable for Patients with Chronic Inflammatory Skin Conditions? A Systematic Review
by: Wynanda A. van Enst, et al.
Published: (2024)

Curbing the lifestyle disease pandemic: making progress on an interdisciplinary research agenda for law and policy interventions
by: Brigit Toebes, et al.
Published: (2017)

Risk of respiratory tract infections and serious infections in psoriasis patients treated with biologics: Results from the BioCAPTURE registry
by: Lara S. van derSchoot, et al.
Published: (2022)

Health Economic Consequences of a Tightly Controlled Dose Reduction Strategy for Adalimumab, Etanercept and Ustekinumab Compared with Standard Psoriasis Care: A Cost-utility Analysis of the CONDOR Study
by: Selma Atalay, et al.
Published: (2020)

Understanding public support for COVID-19 pandemic mitigation measures over time: Does it wear out?
by: John B. F. De Wit, et al.
Published: (2023)

Direct Comparison of Real-world Effectiveness of Biologics for Psoriasis using Absolute and Relative Psoriasis Area and Severity Index Scores in a Prospective Multicentre Cohort
by: Marloes E. van Muijen, et al.
Published: (2022)

Effects and determinants of tuberculosis drug stockouts in South Africa
by: L. E. M. Koomen, et al.
Published: (2019)

A renewed call for transdisciplinary action on NCDs
by: Brigit Toebes, et al.
Published: (2020)

Two cases with generalised bullous cutaneous reactions after COVID‐19 mRNA vaccine Moderna (Spikevax®) and Pfizer-BioNTech (Comirnaty®)
by: Charlotte E. Rinnooy Kan, et al.
Published: (2024)

Shared decision making and medication adherence in patients with COPD and/or asthma: the ANANAS study
by: Maria Achterbosch, et al.
Published: (2023)

Thuis voelen in de buurt: een opgave voor stedelijke vernieuwing Een vergelijkend onderzoek naar de buurthechting van bewoners in Nederland en Engeland
by: Van der Graaf, Peter
Published: (2009)

Thuis voelen in de buurt: een opgave voor stedelijke vernieuwing Een vergelijkend onderzoek naar de buurthechting van bewoners in Nederland en Engeland
by: Van der Graaf, Peter
Published: (2009)

Risk of candidiasis associated with interleukin-17 inhibitors: A real-world observational study of multiple independent sources
by: Linda Davidson, et al.
Published: (2022)